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a  b  s  t  r  a  c  t
Nutritional  supplementation  has  long  been  studied  as  a possible  treatment  alternative  or  as  an  adjunct  to
the  standard  treatments  for common  ailments  and  diseases.  According  to the  latest  research,  the  Chilean
maqui  berry,  Aristotelia  chilensis,  has been  shown  to reduce  postprandial  insulin  levels  by as  much  as fifty
percent.  The  berry,  which  has been  shown  to be  as  effective  as  metformin  at increasing  insulin  sensitivity
and  controlling  blood  glucose  levels,  follows  a simple  mechanism  of  action  that  involves  the  inhibition  of
sodium  dependent  glucose  transporters  in  the small  intestine,  slowing  the rate  at  which  sugars  enter  the
bloodstream  and  thereby  decreasing  blood  sugar spikes  and  the  corresponding  increase  in insulin  levels.
Chronically  high  blood  glucose  levels  have  been  proven  to  play  a significant  role  in the  development  of
cancers,  as diabetics  and  prediabetics  have  been  proven  to have  elevated  risk  of developing  cancerous
growth.  Consistent  dietary  supplementation  with  maqui  berry  may  therefore  indirectly  reduce  the  risk
of cancer,  as  well  as  other  diseases  which  respond  negatively  to hyperglycemia  and  hyperinsulinemia.
© 2019  “Society  information”.  Production  and  hosting  by Elsevier  B.V.  on  behalf  of KeAi
Communications  Co.,  Ltd.  This  is an  open  access  article under  the  CC  BY-NC-ND  license  (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Insulin insensitivity and hyperinsulinemia create a predispos-
ing or gateway environment to a significantly greater risk of cancer.
This paper reviews the pathogenesis of this process, the literature
that supports the efficacy of nutritional supplementation against
cancer, and the new data that suggests that the Chilean maqui berry
extract may  help to control or reduce the incidence of hyperin-
sulinemia, and therefore indirectly help reduce the risk of various
cancers. The berry extract works via the mechanism of slowing gas-
tric emptying, thereby reducing spikes in blood glucose and insulin,
and does not require massive dietary changes which patients have
typically demonstrated low compliance with. The berry extract is
inexpensive, widely available, and to date has shown minimal side
effects.
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2. Claim
Insulin insensitivity, also known as insulin resistance, and
hyperinsulinemia are typically products of a sedentary lifestyle and
poor dietary habits which often include significant amounts of high
glycemic index, or rapidly absorbed, carbohydrates. Historically,
hyperinsulinemia and insulin insensitivity were thought to have
been separate conditions, exclusive from one another. However,
research now suggests that hyperinsulinemia and insulin insensi-
tivity are directly and causally linked. One condition cannot exist
if the other condition does not also concurrently exist [1]. With
an increased duration and consistent ingestion of high glycemic
food sources which rapidly elevate blood sugar levels, and along
with increased adipose deposition (increased body fat levels and
or obesity), cells in the body become more insulin resistant. As
insulin becomes progressively less effective in modulating blood
glucose levels, blood sugar levels rise, initiating additional secretion
of insulin. The chronic, recurrent continuation of this process leads
to hyperinsulinemia. If the chronic increase in insulin and blood
glucose levels are not addressed through dietary changes, lifestyle
changes, medications, or with dietary supplements, then the risk of
diabetes, cancer, and age-related diseases increases significantly.
Longer duration postprandial blood sugar increases are a pri-
mary indicator of insulin insensitivity. New research, as discussed
below, has shown that regular dietary supplementation with a
https://doi.org/10.1016/j.fshw.2019.07.001
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Chilean berry extract may  help slow the absorption of carbo-
hydrates, thus reducing or blunting the degree of postprandial
blood glucose elevations by 15% and postprandial insulin secre-
tion by more than 50%. This would make dietary supplementation
with maqui berry a potentially significant discovery in the clin-
ical approach to reducing insulin insensitivity, hyperinsulinemia,
obesity, diabetes, and cancer [2,3].
3. Epidemiology of cancer and hyperinsulinemia
Diabetes and its most important predisposing factor obesity are
becoming progressively more prevalent in the U.S. and worldwide.
There are over thirty million diabetics in the U.S. and there are over
eighty million people that are considered prediabetic [4]. The inci-
dence of cancer is also growing, with a projected increase of fifty
percent in cancer cases by 2030 [5]. Recent research suggests that
there are strong correlations between obesity, diabetes, and cancer-
related morbidity and mortality. A study conducted in 2017 aimed
to determine where and how hyperinsulinemia played a role in
the pathogenesis of obesity, diabetes, and cancer-related death. In
this study, the participants had no previous history of cancer or
diabetes. Among nearly ten thousand participants, thirty percent
of non-obese participants were found to have hyperinsulinemia
while seventy-five percent of obese participants were found to
have hyperinsulinemia. This suggests a link between obesity and
a higher risk, if not causation, of developing hyperinsulinemia.
Hyperinsulinemia can potentially magnify the likelihood of becom-
ing diabetic. This study also highlighted the finding that the risk of
cancer mortality was far greater in participants with hyperinsu-
linemia, whether they were obese or not [6]. Given the magnitude
of this health issue, these new findings regarding the efficacy of the
maqui extract in reducing postprandial insulin and glucose spikes
are relevant and important.
4. Mechanisms of hyperinsulinemia and cancer
Mounting research suggests a significant correlation between
a greater risk of developing cancer when hyperinsulinemia is
involved. There is a two to three-fold greater risk of developing
breast cancer if a patient has hyperinsulinemia [7]. There is a two
to three-fold greater risk of developing liver cancer if a patient has
hyperinsulinemia [8]. Hyperinsulinemia is also responsible for a
more than two-fold increase in the risk of developing malignant
prostate cancer [9]. Cancers generally cause an increased reliance
on glucose as a primary fuel source at a cellular level. Cancers
tend to form and grow more rapidly in patients with chronically
high blood sugar levels, including those with obesity and or dia-
betes.
While cancer can potentially stem from long term hyperinsu-
linemia, hyperinsulinemia and insulin insensitivity can begin, or be
concurrent with, obesity as discussed in a 2007 study [10]. When
the body is subjected to low exercise levels and a caloric surplus
provided by high carbohydrate, high glycemic food sources, fat is
more rapidly stored. As adipose tissue deposition increases, the
body accumulates more visceral fat mass. Visceral fat is respon-
sible for releasing polypeptides, called cytokines. Cytokines are
the cause of increased systemic inflammation [11]. A 1993 study
showed that cytokines cause cells to produce proteolytic enzymes
and free radicals, both of which negatively affect the cells of the
pancreatic inlet where insulin is produced [12]. Long term insulin
levels and postprandial insulin response can both be compro-
mised, eventually causing hyperinsulinemia, which can lead to an
increased risk of cancer. This relationship was clearly represented
in a 2009 study conducted by Currie et al., which retrospectively
examined over 60,000 diabetic patients. Participants were divided
into groups based on the treatment they received, whether it
was metformin, sulfonylurea, or strictly insulin. Cancer risk was
measured by tumor progression or incidences of breast cancer,
colon cancer, pancreatic cancer, or prostate cancer. Participants
that received treatment with metformin, one of the most com-
monly prescribed medications for diabetics, showed the lowest
risk of developing cancer. Metformin functions as somewhat of an
antagonist to insulin, decreasing the amount of glucose absorbed
by cells. It also increases insulin sensitivity, reducing the amount
of insulin required to respond to blood sugar spikes, and, therefore,
excess insulin in the bloodstream. The participants treated only
with insulin showed the highest risk of developing cancers, partic-
ularly colorectal and pancreatic cancers. However, this increased
risk was  nearly eliminated when patients combined metformin
with their original treatment with insulin. Considering metformin’s
mechanism of action, this study may  present a direct correlation,
although not causation, between hyperinsulinemia and cancer risk
[13]. Many different types of cancer cells have been shown to
grow and metastasize more readily when blood glucose levels are
chronically high [14–16]. Additionally, insulin is a highly anabolic
hormone that may  increase the rate of cancerous cell prolifera-
tion.
This data suggests the following mechanism for the cor-
relation between hyperinsulinemia and the increased risk of
cancers:
HYPERGLYCEMIA → HYPERINSULINEMIA → INCREASED CANCER
RISK
-  high carbohydrate
diet
- insulin insensitivity - increased glucose
metabolism




- increased free radicals
and oxidative damage
5. Nutritional supplementation, cancer, and
hyperinsulinemia
Growing research suggests the association between high insulin
levels and the development of malignancies. According to the liter-
ature, the idea that nutritional supplementation could potentially
reduce the risk of cancer, or support immune system function,
is not new. This very idea was  elaborated on in a review pub-
lished in 1995. Nutritional supplementation has a long-standing
track record of providing efficacious nutritional support in cancer
patients or in helping to reduce risks. Suboptimal levels of some
essential vitamins, minerals and nutrients can increase the likeli-
hood of mortality [17].
6. Vitamins C and D supplementation
Larger doses of intravenous vitamin C and vitamin D have both
been used as nutritional support to treat diseases by bolstering the
immune system and by reducing systemic inflammation that may
correlate with disease. A 2010 review showed that the likelihood
of developing cardiovascular disease was 50% lower in individu-
als that had plasma vitamin C levels in the upper 25th percentile
of the 25,000 participants studied. This may  be due, at least in
part, to vitamin C’s role as an antioxidant that can improve arterial
longevity and reduce plaque buildup, as was  suggested by Linus
Pauling. Vitamin C has also been shown to decrease the risk of
cancer by influencing gene expression and protecting cells from
genetic mutations that may  lead to cancerous growth. Vitamin C
has also been used to treat fatigue, infection, and cold symptoms
[18]. The potential anticancer effects of vitamin D have also been
explored recently. Extensive research has been conducted cover-
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ing a possible link between vitamin D and breast cancer. It has
been shown that there is a significant negative correlation between
circulating vitamin D levels and the risk of developing breast can-
cer. Other research has proposed that the physiology that explains
this phenomenon has to do with the malfunctioning of proper vita-
min  D metabolism in breast epithelial tissue. This may  suggest that
vitamin D has a propensity to affect the cell cycle, cell prolifera-
tion, and cell death Additionally, symptoms of depression, chronic
fatigue, and joint pain have been shown to positively correlate with
low vitamin D levels. Some instances of these symptoms have been
ameliorated with vitamin D supplementation [19].
7. Berberine and cinnamon supplementation
Berberine is a plant derivative that has been used to treat ail-
ments for thousands of years. Berberine has been linked to the
reduction of blood glucose levels and insulin levels. In fact, berber-
ine has been shown to be as effective as metformin, the most
commonly prescribed drug for diabetics, at controlling blood sugar
levels in diabetics. Berberine causes a decrease in HbA1c which
leads to a hypoglycemic effect [20,21]. Even cinnamon has been
implicated in the reduction of blood sugar. Cinnamon helps to make
cells more insulin sensitive and can also help with more efficient
utilization of sugar for energy [22,23].
8. Maqui berry supplementation
New research shows that while the maqui berry extract oper-
ates through a different mechanism of action than the nutritional
supplements discussed, it has been shown to be effective. In addi-
tion to being a rich source of antioxidants, maqui berry acts to
decrease postprandial changes in blood glucose levels by slowing
the rate that sugar enters the blood stream, allowing for a smaller,
more gradual rise in blood glucose levels, resulting in less insulin
secretion.
The mechanism of action is based on the fact that maqui berry
contains powerful peptides called delphinidins that inhibit sodium
dependent glucose transporters located in the small intestine [23].
Therefore, nutrients and sugars that can potentially spike blood
glucose and insulin levels are absorbed through the intestinal wall
and into the portal vein at a slower rate. A recent study showed that
participants taking maqui berry extract had 15% less increase in
blood glucose levels when compared to the placebo group. Insulin
levels were even more heavily affected in the experimental group,
as participants taking maqui berry extract showed more than a 50%
lower peak insulin level post meal when compared to the control
group [3].
MAQUI BERRY → SLOWED GLUCOSE ABSORPTION → LESS
INCREASE IN BLOOD GLUCOSE → LOWER INSULIN RESPONSE
Given the mechanism discussed above, maqui berry may play
a key, albeit indirect role, in reducing cancer risk by decreasing
hyperglycemia, which would decrease hyperinsulinemia.
9. Potential side effects and safety of maqui berry
A review of the literature cited in this article revealed no find-
ings regarding the safety or potential toxicity issues of maqui berry,
though some nutritionists may  advise mothers to avoid use of
such nutritional supplements during pregnancy or breastfeeding.
In addition, there were no findings regarding maqui berry drug
interactions. Literature sources, in general, tend to suggest that as
a natural berry, it is non-toxic. None of the discussed publications
made mention of study participants having to discontinue use of
maqui berry due to a negative response. In rare cases, an allergy to
maqui berry may  cause an undesirable reaction. Further research
is needed in this area. However, as compared to the numerous side
effects of using oral or injectable medications used to treat hyper-
glycemia, maqui berry appears to have significant promise in terms
of being a relatively safe alternative.
10. Discussion
Cancer has been described as a metabolic disorder, and as
such, incidences may  be influenced by a variety of factors includ-
ing lifestyle, exercise, nutritional choices, body composition, and
hormonal levels. the most significant risk factors of cancer may,
therefore, be controllable, such as diet (in terms of total calories,
macronutrient ratios, fiber, and sugar intake), exercise, supplemen-
tation, and body fat levels. In a broader sense, hyperinsulinemia and
insulin resistance can affect the occurrence of diabetes, cancer, and
age-related diseases.
A 2016 study conducted by Alvarado et al. sampled 43 indi-
viduals between the ages of 19 and 50, both male and female. All
subjects presented hypertension, prediabetes, or a high body mass
index. Participants were given maqui berry extract, delphinol, in
doses between 60 and 180 mg  one hour before meals. Postprandial
glucose and insulin dynamics were recorded thirty minutes after
meals, and the results proved to be consistent and dose-dependent.
Higher doses of delphinol showed a lower average postprandial
blood glucose level among participants. Administering higher doses
of delphinol also showed a lower required insulin response to the
same amount of glucose. This suggests that delphinol may  help to
manage the same amount of glucose more effectively and with less
insulin [2].
A 2014 study composed and conducted by a Chilean university
managed to elaborate on the reduced rate of gastric emptying that
maqui berry extract may be responsible for. Delphinidins, derived
from maqui berry extract, were shown to inhibit the sodium-
dependent glucose symports, especially in the jejunum, in humans
and rats. This would, therefore, slow the absorption rate of glucose
in the gastrointestinal tract and minimize spikes in blood glucose
levels. Diabetic rats that were given delphinol for four months
showed a significant reduction in fasted blood glucose levels. After
four months of supplementation, fasting blood glucose levels in dia-
betic rats were nearly indistinguishable from fasted blood glucose
levels in healthy rats. Compared to placebo, pre-prandial delphinol
consumption showed a statistically significant reduction in post-
prandial blood glucose and insulin levels in human subjects [3].
11. Conclusion
Obesity and diabetes-related diseases, such as cancer, continue
to increase, despite the increase in free or cost-efficient access to
exercise programs, body fat reduction dietary programs, and lower
carbohydrate diets. Given the impact and new-found dependence
on technology, sedentary lifestyle habits compound this trend. Con-
sumers, in general, looking for convenient, cost-efficient, relatively
passive solutions to weight gain and dietary challenges.
Other nutritional supplements have shown promising results in
reducing blood sugar and insulin levels and further research is war-
ranted to explore how these ingredients may  work most effectively
in concert in the battle against diabetes and its role as a gateway to
cancer.
By introducing the long-term supplementation of the maqui
berry, the mechanism that leads from obesity and hyperinsu-
linemia to cancer may  be impeded or even prevented. While
further research is necessary, implementing maqui berry as a nutri-
tional supplement, it is possible that chronic insulin levels will be
reduced, insulin sensitivity will be greater, and the risk of develop-
ing cancer will be reduced. The availability, affordability, relative
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safety, and minimally invasive nature and ease of compliance of
the maqui berry supplementation make these results even more
exciting.
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